Pharmaceutical water is used widely in every step of pharmaceutical manufacturing processes to ensure quality and safety. From cleaning equipment and facilities to producing pharmaceutical ingredients, water plays a vital role. High purity water is essential in the production of sterile pharmaceutical products such as injections and sterile ophthalmic preparations. It is also used for cleaning operations and equipment washing during manufacturing to prevent contamination.
The global pharmaceutical water market is estimated to be valued at US$ 6.26 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Stringent regulations regarding the use of pharmaceutical-grade water is one of the key trends driving the growth of the pharmaceutical water market. Regulatory bodies such as the United States Pharmacopeial Convention (USP) and the European Pharmacopoeia have established comprehensive guidelines related to water quality used during various stages of drug manufacturing and processing. As per the regulations, different grades of water including water for injections (WFI), highly purified water (HPW), and purified water (PW) must be used based on the application. The regulations are aimed at ensuring pharmaceutical water meets stringent quality requirements to eliminate contamination risk during manufacturing and help produce safe and high-quality medicines. This growing focus on compliance is boosting the adoption of pharmaceutical water treatment systems across manufacturing facilities.
Segment Analysis
The global pharmaceutical water market is segmented into pure steam water, highly purified water, and purified water. Among these, the highly purified water segment dominates the market and accounts for the largest share. Highly purified water is essential for pharmaceutical production as it is used majorly in sterile preparations such as injections and infusions. It ensures safety, potency, and quality of the manufactured pharmaceutical products.
Key Takeaways
The Global Pharmaceutical Water Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market size is anticipated to reach US$ 12.22 Bn by 2030, expanding at a CAGR of 7.9% over the forecast period.
Regional analysis
North America dominates the global pharmaceutical water market owing to stringent regulations regarding use of pure and highly purified water in pharmaceutical manufacturing. Presence of key pharmaceutical players and availability of advanced treatment technologies are driving the market growth in this region. Asia Pacific is expected to witness fastest growth during the forecast period attributed to growing pharmaceutical industry and increasing investments by major players to expand their presence in emerging markets of India and China.
Key players
Key players operating in the pharmaceutical water market are Sartorius, Merck KGaA, Thermo Fisher Scientific Inc., GENERAL ELECTRIC, Danaher Corporation, SUEZ Water Technologies & Solutions, Veolia Water Solutions and Technologies, Evoqua Water Technologies LLC, Aqua Solutions, Inc., Baxter International Inc. Sartorius and Merck KGaA capture majority share of the market owing to their extensive product portfolio and global presence. Other players are expanding their presence in developing markets through strategic partnerships and acquisitions.
Get more insights on this topic:
https://www.rapidwebwire.com/pharmaceutical-water-market-size-analysis/
